Phio Pharmaceuticals Corp (PHIO)

Apr 03, 2025

Groundbreaking Cancer Treatment Data: Phio's Dual Immunotherapy Candidates Show Promise - Stock Titan

Apr 03, 2025

Apr 03, 2025

3 Reasons to Sell PLCE and 1 Stock to Buy Instead - The Globe and Mail

Apr 03, 2025

Apr 01, 2025

Phio stock hits 52-week low at $1.22 amid sharp annual decline - Investing.com

Apr 01, 2025

Apr 01, 2025

Phio stock hits 52-week low at $1.22 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 01, 2025

Apr 01, 2025

Phio Pharmaceuticals Corp reports results for the quarter ended December 31Earnings Summary - TradingView

Apr 01, 2025

Apr 01, 2025

Virtu Financial LLC Makes New Investment in Phio Pharmaceuticals Corp. (NASDAQ:PHIO) - Defense World

Apr 01, 2025

Mar 31, 2025

Phio Pharmaceuticals Reports 2024 Year End Financial Results and Provides Business Update - TradingView

Mar 31, 2025

Mar 31, 2025

Phio's Cancer Drug Shows Complete Response as Company Slashes Losses by 33% - Stock Titan

Mar 31, 2025

Mar 31, 2025

Phio Pharmaceuticals (PHIO) Expected to Announce Earnings on Monday - Defense World

Mar 31, 2025

Mar 19, 2025

PHIO PHARMACEUTICALS CORP- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com

Mar 19, 2025

Mar 12, 2025

PHIOPhio Pharmaceuticals Corp Latest Stock News & Market Updates - Stock Titan

Mar 12, 2025

Mar 10, 2025

American Academy of Dermatology Awards Podium Presentation to Phio Pharmaceutical's Clinical Research at 2025 Annual Meeting - Quantisnow

Mar 10, 2025

Mar 10, 2025

Phio Reports 50% Complete Response Rate in Skin Cancer Trial - StockTitan

Mar 10, 2025

Mar 05, 2025

Phio Pharmaceuticals Announces Completion of Enrollment in Third Safety Cohort in PH-762 Phase 1b Dose-Escalation Study - Newsfile

Mar 05, 2025

Mar 04, 2025

PHIO stock touches 52-week low at $1.25 amid sharp annual decline - Investing.com Australia

Mar 04, 2025

Feb 28, 2025

Phio Pharma Stock Quadruples On Positive Data From Cancer Treatment Trial: Retail’s Elated - MSN

Feb 28, 2025

Feb 26, 2025

Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series - Newsfile

Feb 26, 2025

Feb 26, 2025

Can Phio's Novel siRNA Cancer Technology Impress Investors at Upcoming Roadshow? - StockTitan

Feb 26, 2025

Feb 25, 2025

PHIO stock touches 52-week low at $1.48 amid market challenges - Investing.com

Feb 25, 2025

Feb 25, 2025

PHIO stock touches 52-week low at $1.48 amid market challenges By Investing.com - Investing.com South Africa

Feb 25, 2025

Feb 22, 2025

Brokers Offer Predictions for PHIO FY2024 Earnings - Defense World

Feb 22, 2025

Feb 22, 2025

Comparing Tharimmune (NASDAQ:THAR) and Phio Pharmaceuticals (NASDAQ:PHIO) - Defense World

Feb 22, 2025

Feb 20, 2025

Phio Pharmaceuticals Appoints David Deming to Board - TipRanks

Feb 20, 2025

Feb 20, 2025

Phio Pharmaceuticals expands board with new director By Investing.com - Investing.com Nigeria

Feb 20, 2025

Feb 20, 2025

Phio Pharmaceuticals Corp. Appoints David H. Deming to Board of Directors -February 20, 2025 at 09:54 am EST - Marketscreener.com

Feb 20, 2025

Feb 20, 2025

H.C. Wainwright maintains Buy rating, $4 target on Phio Pharma stock - Investing.com

Feb 20, 2025

Feb 20, 2025

Phio Pharmaceuticals expands board with new director - Investing.com

Feb 20, 2025

Feb 20, 2025

Phio Pharmaceuticals Announces Appointment of David H. Deming to Board of Directors - Newsfile

Feb 20, 2025

Feb 20, 2025

Phio Pharmaceuticals (NASDAQ:PHIO) Given “Buy” Rating at HC Wainwright - Defense World

Feb 20, 2025

Feb 18, 2025

PHIO Stock: The Biotech Breakthrough You Can't Ignore! Is This the Future of Immunotherapy? - Elblog.pl

Feb 18, 2025

Feb 18, 2025

Reviewing BridgeBio Pharma (NASDAQ:BBIO) & Phio Pharmaceuticals (NASDAQ:PHIO) - Defense World

Feb 18, 2025

Feb 11, 2025

Phio Pharmaceuticals (NASDAQ:PHIO) Shares Down 5.8% – Should You Sell? - Defense World

Feb 11, 2025

Feb 07, 2025

Phio Pharma (NASDAQ:PHIO) Stock Quotes, Forecast and News Summary - Benzinga

Feb 07, 2025

Feb 03, 2025

Inside Phio's Revolutionary siRNA Cancer Treatment: CEO Reveals Clinical Progress - StockTitan

Feb 03, 2025

Jan 25, 2025

Revolutionary Cancer Treatment or Environmental Savior? - Elblog.pl

Jan 25, 2025

Jan 23, 2025

Phio Pharmaceuticals (PHIO) Stock Price, News & Analysis - MarketBeat

Jan 23, 2025

Jan 22, 2025

Phio Pharmaceuticals CEO to Present Breakthrough Cancer Treatment at Renmark Virtual Roadshow - StockTitan

Jan 22, 2025

Jan 21, 2025

Phio Pharmaceuticals Announces Closing of $1.83 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Newsfile

Jan 21, 2025

Jan 17, 2025

We Asked Retail What's Next For Phio Pharma After Monday's Blistering Rally: Most See More Room To Run - MSN

Jan 17, 2025

Jan 16, 2025

Phio Pharmaceuticals Raises $1.83M in Direct Offering with Warrant Coverage at $3.00/Share - StockTitan

Jan 16, 2025

Jan 16, 2025

Stock market news: Phio Pharmaceuticals +50.19%, DatChat +46.01% among top gainers during mid day trading - Business Upturn

Jan 16, 2025

Jan 16, 2025

Phio Pharmaceuticals Announces $1.83 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - FinancialContent

Jan 16, 2025

Jan 15, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

Jan 15, 2025

Jan 15, 2025

Stock market today: Phio Pharmaceuticals -20.76%, Soligenix -20.15% among biggest losers in early trading - Business Upturn

Jan 15, 2025

Jan 15, 2025

Phio Pharmaceuticals Raises $2.5M Through Direct Offering at $3.00 Per Share - StockTitan

Jan 15, 2025

Jan 15, 2025

Phio Pharmaceuticals sharply lower on equity offering - MSN

Jan 15, 2025

Jan 15, 2025

Stock market news: PTL -68.18%, Springview Holdings -41.63% among biggest losers during mid day trading - Business Upturn

Jan 15, 2025